tradingkey.logo
tradingkey.logo
Search

Larimar Therapeutics Inc

LRMR
Add to Watchlist
3.820USD
-0.005-0.13%
Close 07-31 16:00ETQuotes delayed by 15 min
396.83MMarket Cap
LossP/E TTM

LRMR Financials

See Larimar Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Larimar Therapeutics Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.33/-0.54
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.27
-72.60%
Analyst Rating
STRONG BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
27.97%-0.33
-62.21%-0.73
-150.78%-0.61
-20.64%-0.41
-67.30%-0.46
-52.61%-0.45
-17.66%-0.24
-77.86%-0.34
-84.06%-0.27
-38.46%-0.30
---0.21
---0.19
---0.15
---0.21
---1.32
----
----
----
----
----
Net Profit
-1.13%-29.61M
-116.83%-62.50M
-207.84%-47.71M
-21.06%-26.18M
-99.82%-29.28M
-121.84%-28.82M
-71.00%-15.50M
-158.51%-21.63M
-124.55%-14.65M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
-3.19%-9.43M
50.49%-8.32M
31.26%-8.67M
26.02%-8.94M
35.69%-9.13M
-63.57%-16.80M
-11.29%-12.61M
Operating profit
0.23%-31.12M
-104.58%-64.02M
-171.02%-49.50M
-12.98%-27.79M
-86.38%-31.19M
-120.96%-31.29M
-76.65%-18.26M
-155.71%-24.60M
-119.12%-16.73M
-35.66%-14.16M
-21.45%-10.34M
-10.74%-9.62M
14.07%-7.64M
-14.89%-10.44M
49.12%-8.51M
30.74%-8.69M
26.59%-8.89M
36.89%-9.09M
-61.88%-16.73M
-10.04%-12.54M
Net Profit
-1.13%-29.61M
-116.83%-62.50M
-207.84%-47.71M
-21.06%-26.18M
-99.82%-29.28M
-121.84%-28.82M
-71.00%-15.50M
-158.51%-21.63M
-124.55%-14.65M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
-3.19%-9.43M
50.49%-8.32M
31.26%-8.67M
26.02%-8.94M
35.69%-9.13M
-63.57%-16.80M
-11.29%-12.61M
Current assets
23.86%204.98M
-27.28%142.02M
-14.08%183.22M
-37.02%145.56M
-28.35%165.49M
116.58%195.30M
116.55%213.26M
117.07%231.13M
103.55%230.95M
-25.31%90.17M
-22.53%98.48M
87.65%106.48M
74.89%113.46M
67.22%120.74M
56.46%127.13M
-23.36%56.74M
-24.67%64.88M
-26.29%72.20M
-24.64%81.25M
-37.84%74.04M
Total current liabilities
115.76%47.76M
166.03%64.80M
177.04%45.12M
25.97%26.65M
72.37%22.13M
156.22%24.36M
148.32%16.29M
190.79%21.16M
60.31%12.84M
-11.20%9.51M
-30.38%6.56M
-5.75%7.28M
-9.73%8.01M
21.02%10.71M
-8.60%9.42M
0.36%7.72M
5.95%8.87M
-1.62%8.85M
99.03%10.31M
15.74%7.69M
Total assets
22.53%208.51M
-27.16%145.84M
-14.46%187.35M
-36.76%149.99M
-31.44%170.18M
108.71%200.22M
110.69%219.02M
112.29%237.16M
108.74%248.21M
-24.11%95.94M
-21.85%103.95M
77.74%111.72M
66.95%118.91M
60.68%126.41M
51.26%133.01M
-22.34%62.85M
-23.43%71.22M
-24.85%78.67M
-22.83%87.94M
-35.49%80.93M
Total liabilities
94.87%50.48M
138.47%67.76M
134.29%48.31M
16.99%30.13M
49.21%25.90M
99.88%28.41M
83.46%20.62M
118.55%25.76M
37.07%17.36M
-8.30%14.21M
-21.69%11.24M
-7.89%11.79M
-10.28%12.67M
8.76%15.50M
-9.56%14.35M
-4.55%12.80M
-0.82%14.12M
-4.94%14.25M
40.25%15.87M
3.82%13.41M
Total equity
9.54%158.03M
-54.55%78.08M
-29.92%139.04M
-43.31%119.85M
-37.50%144.27M
110.24%171.81M
114.00%198.40M
111.55%211.40M
117.28%230.84M
-26.31%81.72M
-21.87%92.71M
99.64%99.93M
86.05%106.24M
72.17%110.90M
64.66%118.66M
-25.87%50.06M
-27.52%57.10M
-28.18%64.41M
-29.79%72.07M
-40.00%67.53M
Net operating income
-68.10%-44.61M
-76.61%-38.53M
-17.14%-28.75M
-38.55%-19.38M
-154.92%-26.54M
-133.49%-21.82M
-166.80%-24.55M
-89.93%-13.99M
-37.88%-10.41M
-40.03%-9.34M
-56.52%-9.20M
1.62%-7.37M
-0.24%-7.55M
15.74%-6.67M
51.82%-5.88M
30.57%-7.49M
32.78%-7.53M
19.67%-7.92M
-8.71%-12.20M
34.67%-10.78M
Net investment
100.72%29.00M
77.11%34.00M
21.07%33.02M
129.68%18.84M
121.13%14.45M
830.20%19.20M
158.74%27.27M
-545.38%-63.49M
-174.11%-68.36M
94.97%-2.63M
-1272.04%-46.43M
72.16%-9.84M
--92.25M
-904.84%-52.23M
50.17%-3.38M
-283.89%-35.34M
-100.00%0.00
127.56%6.49M
-84787.50%-6.79M
-14.39%19.22M
Net financing
--108.11M
-658.33%-201.00K
217523.33%65.29M
100.00%0.00
-100.00%0.00
--36.00K
0.00%30.00K
---334.00K
--162.15M
100.00%0.00
-99.96%30.00K
----
--0.00
---316.00K
280.05%75.57M
--0.00
--0.00
-100.00%0.00
14829.63%19.89M
-100.00%0.00

FAQs

What are the current assets of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its current assets were 142.02M, with a year-on-year change of -27.28.

What are the total assets of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its total assets of Larimar Therapeutics Inc were 145.84M, with a year-on-year change of -27.16.

What are the total liabilities of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its total liabilities of Larimar Therapeutics Inc were 67.76M, with a year-on-year change of 138.47.

What is the total equity of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its total equity of Larimar Therapeutics Inc was 78.08M, with a year-on-year change of -54.55.

What is the net operating income of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its net operating income of Larimar Therapeutics Inc was -172.50M, with a year-on-year change of -89.79.

What is the net investment of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its net investment of Larimar Therapeutics Inc was 100.31M, with a year-on-year change of 217.48.

What is the net financing of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its net financing of Larimar Therapeutics Inc was 65.09M, with a year-on-year change of -59.79.

What is the Earnings Per Share (EPS) of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.27, with a year-on-year change of -72.60.

What is the net income of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its net income was -165.67M, with a year-on-year change of -105.54.

What is the Return on Equity (ROE) of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -132.59, with a year-on-year change of -108.53.

What is the Return on Assets (ROA) of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -95.75, with a year-on-year change of -75.90.

What is the operating profit of Larimar Therapeutics Inc?

According to Larimar Therapeutics Inc's FY2025 earnings report, its operating profit was -172.50M, with a year-on-year change of -89.79.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.